VALFIX Medical Inc. announced today the appointment of former Abbott Venture Divisional Vice President (DVP), Mr. Evan Norton as the company’s independent board member making him the company’s fifth board of directors’ member.
“We are delighted to have Evan on VALFIX’s board of directors. His business and market experience and talents in MedTech innovation are extremely valuable assets as VALFIX continues to grow and we continue to advance our technology,” commented Eli Bar, CEO, and Chairman of the board. “Together, with Evan and the rest of our board, we look forward to our continued success in driving the VALFIX technology toward achieving our goals.”
Mr. Norton spent a decade with Abbott leading the corporate venture arm, Abbott Ventures. During this time, Mr. Norton managed the company’s minority equity investments, structured transactions, and private company acquisitions on behalf of both Abbott’s business units as well as developing entry strategies in white space markets.
“I am delighted to join VALFIX’s board of directors. When I was approached by Eli Bar with this opportunity and, after learning more about the VALFIX team and technology potential, I knew it was a company I wanted to be involved with,” stated Evan. “I am confident in Eli’s leadership, VALFIX’s success to date in achieving their milestones, and the ongoing potential of the company.
Mr. Norton has an MBA from Northwestern’s Kellogg School of Management where he serves as an adjunct lecturer teaching “Medical Products Commercialization and Funding.”